Jubilant Life Sciences is currently trading at Rs. 220.00, up by 0.90 points or 0.41% from its previous closing of Rs. 219.10 on the BSE.
The scrip opened at Rs. 220.00 and has touched a high and low of Rs. 223.65 and Rs. 219.15 respectively. So far 7975 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 248.25 on 10-Dec-2012 and a 52 week low of Rs. 154.00 on 06-Aug-2012.
Last one week high and low of the scrip stood at Rs. 223.65 and Rs. 202.05 respectively. The current market cap of the company is Rs. 3535.24 crore.
The promoters holding in the company stood at 49.04% while Institutions and Non-Institutions held 28.83% and 22.13% respectively.
Jubilant Life Sciences has reported results for third quarter ended December 31, 2012.
The company, on consolidated basis, has reported net profit of Rs 26.69 crore for the quarter as compared to a net loss of Rs 78.39 crore for the same quarter in the previous year. Total income from operation of the company has increased by 19.27% at Rs 1306.39 crore for quarter under review as compared to Rs 1095.25 crore for the quarter ended December 31, 2011.
Jubilant Life Sciences is an integrated Pharmaceuticals and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution provider out of India.
